Home | 113botanicals.com

At 113 Botanicals

we believe

The Plant Knows Best ™

Innovation in plant extraction & medicinal biotech design

Groundbreaking Medical Cannabis Technologies

Since 2019, 113 Botanicals has been developing innovative technologies for the extraction of GMP grade cannabinoid extracts for the pharmaceutical and medical markets.

Using our own extract, 113 Botanicals has developed a unique, controlled and sustained-release capsule with the aim to address significant unmet medical needs.

Harnessing Science to bring the best out of Nature

113 Botanicals takes our expertise in the fields of botanical extraction engineering and medicinal biotech process design and implementation and combines this with ground-breaking new research.

Our mission is to harness our scientific expertise to develop high quality CBPMs and innovative routes of administration, all with a focus on the highest standards of safety, efficacy and affordability.

Our research collaboration with the School of Life Sciences, University of Sussex puts some of the most internationally renowned research scientists, pharmacists and medicinal chemists together to help us further refine our processes and develop our cannabis-derived medicinal products to GMP standard.

Inspiration

I’m delighted to be involved in this fascinating research and development collaboration between the University of Sussex and 113 Botanicals. This partnership has shown the potential to yield unique, GMP compliant materials which will facilitate both more rigorous scientific research into the field of cannabinoids in the UK and help elucidate the health benefits of CBPMs.

This venture started as a chat over a coffee with Dr Maz Nicola and Dr Sue Baxter’s team and then a journey leading to the first Home Office licence of its type at the University. To see something develop from concept to reality, especially given its medical relevance and societal impact, is all the more rewarding

With the help of Sussex Innovations, we have been able to maintain a productive relationship with 113 Botanicals over many years, which has underpinned the success of the project. I am excited to be able to continue our involvement during the next phase where we move towards scale-up and manufacturing of the products developed in our labs at the Chemistry Department at Sussex.”